Ryse Asset Management
RYSE Asset Management LLP is a London-based, FCA-authorised early-stage venture capital firm investing in HealthTech across digital diagnostics, digital therapeutics, medical devices and health data platforms. Founded by clinicians, researchers and entrepreneurs, it backs companies between seed and Series A. Its RYSE Special Opportunities Fund, a USD 50m vehicle, announced its first close on 5 March 2024 with Future Care Capital as a cornerstone investor. Incorporated as an LLP in 2010, the firm relaunched its brand in 2017.
Key facts
Recent exits
No exits recorded yet.
Coverage notes
1 fund tracked, 6 portfolio companies (6 active · 0 realized). Verified weekly from public filings and deal announcements.
Sector breakdown
6 companiesFunds & portfolio
Every fund Ryse Asset Management has raised, with its portfolio companies. Hand-checked from public filings.
RYSE Special Opportunities FundVC2024 · 2yr€46M6 active
Unrealized
6 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| HealthTech |  Spain | 2024 | |
| HealthTech |  US | 2024 | |
| HealthTech |  Portugal | 2020 | |
| HealthTech |  UK | 2020 | |
| HealthTech | UK | 2022 | |
| Biotech | US | 2026 |
Spain· Entry 2024US· Entry 2024Portugal· Entry 2020UK· Entry 2020UK· Entry 2022US· Entry 2026Saved GPs appear in your watchlist, one click from your workspace.
About Ryse Asset Management
Ryse Asset Management is a British private equity and investment platform with capital deployed across 2 active fund vehicles, headquartered in London. The firm operates across multiple alternative strategies, with capital deployed into European businesses across TMT, consumer, healthcare, financials, industrials and energy.
Investment thesis
Ryse Asset Management operates across complementary alternative investment strategies, deploying capital into European businesses across TMT, consumer, healthcare, financials, industrials and energy. The multi-strategy platform enables diversified capital deployment across the business lifecycle from venture and growth equity to mid-cap buyouts, with capital sourced from institutional limited partners and selective family-office capital across the United Kingdom and broader European market.
Recent activity
Realised exits across the current platform vintages remain limited, with the portfolio in active deployment and value-creation phase. The platform tracks 2 fund vehicles, 37 active portfolio companies and 0 realised exits across the strategy's history. Detailed buyer names and multiple data available on Pro at €29/month.
Investment team
Senior partners. Hand-checked from public filings and the firm's own site.
Similar firms
Other private equity firms tracked on GP Intel.
United Kingdom·€309.0B
United Kingdom·€15.4B
United Kingdom·€12.7B
United Kingdom·€11.7B
United Kingdom·€6.4B
United Kingdom·€4.1B
United Kingdom·€3.5B
United Kingdom·€2.3B
United Kingdom·€2.3B
United Kingdom·€1.8B
United Kingdom·€1.8B
United Kingdom·€1.6BGet the full picture on Ryse Asset Management.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Already a member? Sign in